
Sign up to save your podcasts
Or


Send us a text
Nick talks to Dr. Alan Davis, a clinical psychologist and Director of the Center for Psychedelic Drug Research & Education at Ohio State University. They discuss: the effectiveness of mainstream forms of psychotherapy and antidepressant medications (SSRIs) for depression; psychedelic medicine & psilocybin-assisted psychotherapy; the relevance of the subjective effects of psychedelics for their therapeutic effects; FDA approval for MDMA- and psilocybin-assisted psychotherapy in the coming years; and more.
*Not medical advice.
Support the show
Affiliates:
For all the ways you can support my efforts
By Nick Jikomes4.8
7878 ratings
Send us a text
Nick talks to Dr. Alan Davis, a clinical psychologist and Director of the Center for Psychedelic Drug Research & Education at Ohio State University. They discuss: the effectiveness of mainstream forms of psychotherapy and antidepressant medications (SSRIs) for depression; psychedelic medicine & psilocybin-assisted psychotherapy; the relevance of the subjective effects of psychedelics for their therapeutic effects; FDA approval for MDMA- and psilocybin-assisted psychotherapy in the coming years; and more.
*Not medical advice.
Support the show
Affiliates:
For all the ways you can support my efforts

553 Listeners

7,247 Listeners

5,022 Listeners

1,545 Listeners

2,337 Listeners

309 Listeners

706 Listeners

368 Listeners

49 Listeners

245 Listeners

112 Listeners

60 Listeners

117 Listeners

68 Listeners

3,093 Listeners